LigaChem Biosciences Revenue

LigaChem Biosciences had revenue of 51.58B KRW in the quarter ending March 31, 2025, with 66.07% growth. This brings the company's revenue in the last twelve months to 146.42B, up 154.45% year-over-year. In the year 2024, LigaChem Biosciences had annual revenue of 125.90B with 268.71% growth.

Revenue (ttm)

146.42B

Revenue Growth

+154.45%

P/S Ratio

33.85

Revenue / Employee

861.28M

Employees

170

Market Cap

4,955.66B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	125.90B	91.75B	268.71%
Dec 31, 2023	34.15B	733.60M	2.20%
Dec 31, 2022	33.41B	1.26B	3.90%
Dec 31, 2021	32.16B	-25.34B	-44.07%
Dec 31, 2019	57.50B	32.26B	127.81%
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro
Dec 31, 2014	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Samsung Biologics	4,898.69B
Celltrion	3,662.23B
ALTEOGEN	151.65B
Yuhan	2,114.76B
SK Biopharmaceuticals	578.00B
HLB Co., Ltd.	74.64B
PharmaResearch	392.31B
Peptron	4.30B

Revenue Rankings